Topics

Multiagent Regimens Continue to Spearhead Progress in Late Relapsed Myeloma

17:17 EDT 13 Aug 2019 | OncLive

Peter Voorhees, MD, discusses the recent data with triplet regimens in late relapsed multiple myeloma and other novel agents shaking up the paradigm.

Original Article: Multiagent Regimens Continue to Spearhead Progress in Late Relapsed Myeloma

NEXT ARTICLE

More From BioPortfolio on "Multiagent Regimens Continue to Spearhead Progress in Late Relapsed Myeloma"

Quick Search